Evidence map›Paper›PMID 40018634›Full record

ArticleBMJ public health2024

Identifying climatic drivers of respiratory syncytial virus (RSV) seasonality in Antananarivo, Madagascar, 2011-2021: a sentinel surveillance study.

Tsiry Hasina Randriambolamanantsoa, Norosoa Harline Razanajatovo, Hafaliana Christian Ranaivoson, Laurence Randrianasolo, Hasina Joelinotahiana Rabarison, Helisoa Razafimanjato, Arvé Ratsimbazafy, Danielle Aurore Doll Rakoto, Jean-Michel Heraud, Vincent Lacoste and 1 more

Abstract read
In one paragraph

Article in BMJ public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tsiry Hasina RandriambolamanantsoaNational Influenza Center, Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.ORCID 0009-0009-7200-0687
Norosoa Harline RazanajatovoNational Influenza Center, Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.ORCID 0000-0003-2063-3932
Hafaliana Christian RanaivosonDepartment of Ecology and Evolution, University of Chicago, Chicago, Illinois, USA.
Laurence RandrianasoloNational Influenza Center, Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Hasina Joelinotahiana RabarisonNational Influenza Center, Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Helisoa RazafimanjatoNational Influenza Center, Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Arvé RatsimbazafyNational Influenza Center, Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Danielle Aurore Doll RakotoDoctoral School of Life and Environment Sciences, Faculty of Sciences, University of Antananarivo, Antananarivo, Madagascar.
Jean-Michel Heraud *National Influenza Center, Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Vincent Lacoste *National Influenza Center, Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.ORCID 0000-0002-3173-4053
Cara E Brook *Department of Ecology and Evolution, University of Chicago, Chicago, Illinois, USA.

Funding

NCIRD CDC HHS U51 IP000812
6 · The paper itself

Abstract

Introduction: Respiratory syncytial virus (RSV) is a primary source of acute lower respiratory tract infection, the leading cause of death in children under 5. Over 99% of RSV-attributed deaths occur in low-income countries, including Madagascar. RSV transmission is linked to climate, driving highly seasonal dynamics. Methods: We used generalised additive models (GAMs) to identify correlates of reported RSV infections in Antananarivo, Madagascar, from January 2011 to December 2021, then fit catalytic models to cumulative age-structured incidence to estimate age-specific force of infection (FOI). We fit a time-series susceptible-infected-recovered (TSIR) model to the dataset to estimate weekly RSV transmission, then evaluated associations with precipitation, humidity and temperature using generalised linear models. We used GAMs to quantify interannual trends in climate and assess whether significant deviations in RSV burden occurred in years representing climatic anomalies. Results: Reported RSV infections in Antananarivo were significantly associated with patients aged ≤2 years. Highest FOI was estimated in patients aged ≤1 year, with transmission declining to near-zero by age 5 before rising in older (60+) cohorts. TSIR models estimated a January to February peak in RSV transmission, which was strongly positively associated with precipitation and more weakly with temperature but negatively related to relative humidity. Precipitation, humidity and temperature all increased across the study period in Antananarivo, while reported RSV infections remained stable. Significant deviations in RSV burden were not associated with clear climate anomalies. Conclusions: Stable rates of reported RSV infections in Antananarivo across the past decade may reflect contrasting impacts of elevated precipitation and increased humidity on transmission. If future climate changes yield more rapidly accelerating precipitation than humidity, this could accelerate RSV burden. Introduction of recently developed public health interventions to combat RSV in low-income settings like Madagascar is essential to mitigating disease burden, in particular to combat any future climate-driven increases in transmission or severity.

Indexed as

EpidemiologyPublic HealthSentinel Surveillance

Identifiers

PMID40018634
PMCPMC11816425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.